KATE ANN POPET
Prescription History 1720836729
Nurse Practitioner - Family in Halfmoon, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for KATE ANN POPET, an active Family specialist practicing in Halfmoon, NY. Our medical registry currently tracks 8 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 325 documented patient claims. Among these therapy options, the most frequently utilized medication is Sertraline Hcl, which accounts for 77 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other NY PrescribersVs. NY Avg |
|---|---|---|---|
| Sertraline Hcl | 77 | $8.50▼ below NY avg | ≈ Typical |
About Sertraline Hcl: This medication is used to treat certain mental/mood disorders (such as depression, panic attacks, obsessive compulsive disorder, post-traumatic stress disorder, social anxiety disorder). Show more ▾ It is also used to treat a severe form of premenstrual syndrome (premenstrual dysphoric disorder). Sertraline belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. A selective serotonin uptake inhibitor that is used in the treatment of depression. In 2024, this provider wrote 77 Medicare prescriptions for Sertraline Hcl, about 1.2 times the volume of the typical New York prescriber of this medication (62.6). Medicare paid an average of $8.50 per fill, versus $8.54 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 143.8 30-Day Fills standardized to 30-day supplies 4,314 Days of Medication total across all patients in 2024 | |||
| Galantamine ErGalantamine Hbr | 56 | $107.13 | ≈ Typical |
About Galantamine Er: Galantamine is used to treat mild to moderate confusion (dementia) related to Alzheimer's disease. Show more ▾ It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by restoring the balance of certain natural substances (neurotransmitters) in the brain. A benzazepine derived from norbelladine. It is found in GALANTHUS and other AMARYLLIDACEAE. It is a cholinesterase inhibitor that has been used to reverse the muscular effects of GALLAMINE TRIETHIODIDE and TUBOCURARINE and has been studied as a treatment for ALZHEIMER DISEASE and other central nervous system disorders. In 2024, this provider wrote 56 Medicare prescriptions for Galantamine Er, about the same volume as the typical New York prescriber of this medication (52.5). Medicare paid an average of $107.13 per fill, versus $90.43 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 124 30-Day Fills standardized to 30-day supplies 3,720 Days of Medication total across all patients in 2024 | |||
| Memantine Hcl | 52 | $32.58 | ≈ Typical |
About Memantine Hcl: Memantine is used to treat moderate to severe confusion (dementia) related to Alzheimer's disease. Show more ▾ It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by blocking the action of a certain natural substance in the brain (glutamate) that is believed to be linked to symptoms of Alzheimer's disease. AMANTADINE derivative that has some dopaminergic effects. It has been proposed as an antiparkinson agent. In 2024, this provider wrote 52 Medicare prescriptions for Memantine Hcl, about 83% of the volume of the typical New York prescriber of this medication (62.4). Medicare paid an average of $32.58 per fill, versus $26.68 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 91.4 30-Day Fills standardized to 30-day supplies 2,651 Days of Medication total across all patients in 2024 | |||
| Donepezil Hcl | 51 | $17.00 | ≈ Typical |
About Donepezil Hcl: Donepezil is used to treat confusion (dementia) related to Alzheimer's disease. Show more ▾ It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to function. This medication is an enzyme blocker that works by restoring the balance of natural substances (neurotransmitters) in the brain. An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE. In 2024, this provider wrote 51 Medicare prescriptions for Donepezil Hcl, about 75% of the volume of the typical New York prescriber of this medication (67.6). Medicare paid an average of $17.00 per fill, versus $10.95 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 119.3 30-Day Fills standardized to 30-day supplies 3,580 Days of Medication total across all patients in 2024 | |||
| Quetiapine Fumarate | 37 | $11.23▼ below NY avg | ▼ Less than typical |
About Quetiapine Fumarate: This medication is used to treat certain mental/mood disorders (such as schizophrenia, bipolar disorder, sudden episodes of mania or depression associated with bipolar disorder). Show more ▾ Quetiapine belongs to a class of drugs known as atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain. A dibenzothiazepine and ANTIPSYCHOTIC AGENT that targets the SEROTONIN 5-HT2 RECEPTOR; HISTAMINE H1 RECEPTOR, adrenergic alpha1 and alpha2 receptors, as well as the DOPAMINE D1 RECEPTOR and DOPAMINE D2 RECEPTOR. It is used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER and DEPRESSIVE DISORDER. In 2024, this provider wrote 37 Medicare prescriptions for Quetiapine Fumarate, about 64% of the volume of the typical New York prescriber of this medication (58). Medicare paid an average of $11.23 per fill, versus $16.33 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 53.5 30-Day Fills standardized to 30-day supplies 1,555 Days of Medication total across all patients in 2024 | |||
| Trazodone Hcl | 21 | $4.13▼ below NY avg | ▼ Less than typical |
About Trazodone Hcl: This medication is used to treat depression. Show more ▾ Trazodone works by helping to restore the balance of a certain natural substance (serotonin) in the brain. A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309) In 2024, this provider wrote 21 Medicare prescriptions for Trazodone Hcl, about a third of the volume of the typical New York prescriber of this medication (57.3). Medicare paid an average of $4.13 per fill, versus $7.91 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 29 30-Day Fills standardized to 30-day supplies 870 Days of Medication total across all patients in 2024 | |||
| Escitalopram Oxalate | 17 | $10.47 | ▼ Less than typical |
About Escitalopram Oxalate: This medication is used to treat certain mental/mood disorders (such as depression, anxiety). Show more ▾ Escitalopram belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. S-enantiomer of CITALOPRAM. Belongs to a class of drugs known as SELECTIVE SEROTONIN REUPTAKE INHIBITORS, used to treat depression and generalized anxiety disorder. In 2024, this provider wrote 17 Medicare prescriptions for Escitalopram Oxalate, about a third of the volume of the typical New York prescriber of this medication (57.7). Medicare paid an average of $10.47 per fill, versus $10.03 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34 30-Day Fills standardized to 30-day supplies 1,016 Days of Medication total across all patients in 2024 | |||
| Risperidone | 14 | $10.19▼ below NY avg | ▼ Less than typical |
About Risperidone: This medication is used to treat certain mental/mood disorders (such as schizophrenia, bipolar disorder, irritability associated with autistic disorder). Show more ▾ Risperidone belongs to a class of drugs known as atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain. A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA. In 2024, this provider wrote 14 Medicare prescriptions for Risperidone, about a quarter of the volume of the typical New York prescriber of this medication (54.1). Medicare paid an average of $10.19 per fill, versus $13.78 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 16 30-Day Fills standardized to 30-day supplies 400 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for KATE ANN POPET is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Family prescribing approach at this Halfmoon, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among NY prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
